Do Negative Trials Count More Than Successful Ones?
This article was originally published in The Pink Sheet Daily
Executive Summary
Fabre-Kramer, FDA dispute over efficacy of the antidepressant gepirone heads to Psychopharmacologic Drugs Advisory Committee.